In particular, ABI is to be used in combination with corticosteroids to suppress the action of the adrenocorticotropic hormone (ACTH) and to limit the occurrence and severity of hypertension, hypokalemia, fluid retention, and cardiac failure [44]. This evidence concerns the gene POMC and heart failure.